Beyond Headlines Into Insight
The UK-company is based on the development, production and sale of the medicines and agreed two commercial contracts on May 24 and September 5. The supply of product follows the successful completion of the company’s latest harvest from its UK-based facility, which is being used to fulfil its commercial contracts. Periodic invoicing has now commenced
Read More
Atropos Health translates real-world clinical date into personalized real-world evidence and insights announced its partnership with SEQESTER today (December 14). Healthcare and life science organizations which use the Atropos Health Evidence Network can establish turnkey patient registries to accelerate evidence generation. This process, the companies say, previously costing millions and requiring up to a year,
Read More
Deep Apple Therapeutics discovers the therapeutics for high-value targets through virtual screening of artificial intelligence (AI)-generated virtual libraries. With a powerful discovery engine that combines ensemble cryo-EM, deep learning, and molecular docking screens of ultra-large libraries, Deep Apple can go from target identification to lead optimization in less than 12 months – a fraction of
Read More
Up to 160 adults with increased risk for acute kidney injury (AKI) following cardiac surgery are planned to be recruited for the study from multiple sites in North America and Europe. The double-blind, placebo-controlled trial is expected to begin early next year and is intended to show that MTX652 protects this high-risk group of patients
Read More
UK-based biotech, CellCentric which spun out of Cambridge University has yesterday (December 11) announced new clinical data for the drug at the American Society for Hematology (ASH) in San Diego. The results follow a recent publication in the Cancer Cell journal, which describes the novel mechanism of action of inobrodib, a first in a new
Read More
She discovered a passion for science after her very first chemistry lesson and found the subject came easily to her. To find out more about her and how she overcame the challenges of being the first woman scientist in her lab and finding her way in a male-dominated industry. Could you give us an overview
Read More
The company will now work with the faculty of pharmacy at Universiti Teknologi MARA (UiTM) with the partnership focused on advancing research initiatives on the use of machine learning tools to predict Alzheimer’s Disease using blood via academic-industry partnerships. Farid Khan, CEO of PharmaKure, (pictured below right) said: “The UK has an aging population, where
Read More
Established in 1994 and funded by the National Institutes of Health and National Cancer Institution has opted to use Proscia’s Concentriq for Research, a provider of digital and computational pathology solutions to encourage scientific exploration and discovery in cancer as well as PLWH. The ACSR says its mission is to ‘acquire, store, and equitably distribute
Read More
UK-based biotech, CellCentric which spun out of Cambridge University has today (December 11) announced new clinical data for the drug at the American Society for Hematology (ASH) in San Diego. The results follow a recent publication in the Cancer Cell journal, which describes the novel mechanism of action of inobrodib, a first in a new
Read More
The Aiddison drug discovery software works through Synthia retrosynthesis software application programming interface (API) integration and Merck says it combines generative artificial intelligence (AI), machine learning, and computer-aided drug design to speed up drug development. Trained on more than two decades of experimentally validated datasets from pharmaceutical research and development, Aiddison software identifies compounds from
Read More
As director of strategic growth and technical sales plus pharmaceutical ingredients, she has given us a comprehensive overview. OSP: Can you tell me why the distribution and sourcing of pharmaceutical ingredients is so important? MW: Interestingly, but not surprisingly, distribution got its start in ancient military times. Romans and Greeks used logistics and distribution
Read More
It will add to the existing in-vitro biology capabilities with the addition of primary and secondary screening capabilities of compounds prepared at the Indian site. Piramal Pharma Limited’s Pharma Solutions (PPS) business is a leading Contract Development and Manufacturing Organization (CDMO) and with this expansion it is well positioned to provide clients with an integrated
Read More
There is an ongoing digital shift in clinical trials, and as a result, companies are continuously striving to improve both patient experience and clinical data quality. The 21st Century Cures Act which became law in the US in December 2016, paved the way for companies to develop new technology that is capable of improving the
Read More
The CDMO has launched the new in-house analytical and microbiological capabilities that will enable the testing. Fully approved by the UK Regulatory Agency, the MHRA, this expansion of their service offering will strategically enhance the companies’ core sterile manufacturing service, that is also referred to as ‘fill/finish’ and provide an extensive in-house quality control (QC)
Read More
Takeda announced at the end of last month (November 2023) that it had been approved by the US Food and Drug Administration (FDA) on November 9, 2023. cTTP is a very rare, complex condition that can present as an acute life-threatening disorder requiring prompt diagnosis, early referral, and effective immediate and ongoing management in a
Read More
Qualicaps manufactures hard capsules and pharmaceutical-related equipment and is the third-largest producer for oral dosage solutions. The company is a ‘renowned global player, relying on high-quality products and a strong innovation pipeline’. It has a workforce of 1,400 employees located in different sites in Asia, Europe, and the Americas. Roquette is a family-owned global leader
Read More
There is still a general sense of wariness from some sectors within the life sciences and we discussed why this might be, what businesses can do to reassure clients and staff and how machines are not quite set to take people’s jobs yet. OSP: A lot of people are wary about artificial intelligence, including within
Read More
At the same time, the company has announced the closing of a strategic investment round with new investor Novartis (dRx Capital) joining existing investors Eli Lilly, Next Stage AM and Wille Finance. Included in the trials, Yseop says, are many of the most notable advancements in new treatments, vaccines and medicines that have emerged recently.
Read More
She has successfully guided many biotech and life science companies across their end-to-end clinical development journey and has commercialized and launched over 25 pharmaceutical and medical device products into global markets. BPR: Could you give me an overview of the work you do at Bios Health Group and what the company focuses on? At Bios
Read More
The California-based start-up claims that, by removing gravity, they are able to make medicines that are not viable on earth. “Processing in a microgravity environment dramatically alters buoyancy, natural convection, sedimentation, phase separation and drives significant differences in transport-driven phenomena,” the company’s website reads. Essentially, Varda argues that drug formulations, both small molecules and biologics,
Read More
BPR: What is Alcohol Use Disorder (AUD) and why is it a major health, social and financial problem? Alcohol Use Disorder (AUD) is a chronic disease characterized by an individual regularly consuming a quantity of alcohol which is harmful to them both physically and socioeconomically. It is believed that there are over 200 physical and
Read More
TGCT is a benign tumor of the joints that can cause swelling, pain, stiffness, and limited mobility of the affected joints. Treatment options for this disease, which can seriously affect patients’ quality of life, are very limited. The agreement grants Merck an exclusive license to commercialize pimicotinib in mainland China, Hong Kong, Macau and Taiwan,
Read More
While obese patients lost significant amounts of weight, many reported high rates of side effects such as nausea and vomiting. “While the most common adverse events were mild and gastrointestinal in nature consistent with the mechanism, high rates were observed, up to 73% nausea, 47% vomiting and 25% diarrhea,” the pharma giant said. “High discontinuation
Read More
Announced today (December 4), the agreement will combine Absci’s Integrated Drug Creation platform with AstraZeneca’s expertise in oncology, to accelerate the discovery of a potential new cancer treatment. Absci will contribute its pioneering generative AI technology to deliver a therapeutic candidate antibody for a specified oncology target. The agreement includes an upfront commitment, R&D funding,
Read More
The round was led by Index Ventures with participation from Kindred Capital and takes the total raised by the company to date to $33 million. The company will use this funding to accelerate its growth, expand its machine learning and biotech team and continue to invest in its product development and sales capabilities. Since exiting
Read More
The company is seeking approval of Rybrevant (amivantamab) in combination with chemotherapy (carboplatin and pemetrexed), a drug it believes has the potential to offer a new standard of care to patients. The treatment is for adult patients with advanced non-small cell lung cancer (NSCLC) with a mutated form of the protein epidermal growth factor receptor
Read More
The treatments are intended for a number of chronic health conditions including chronic pain, severe IBS, sleep disorders, and neurological conditions like Parkinson’s, epilepsy, and motor neurone disease. This decision marked the legalization of medical cannabis in the UK. Releaf, the UK’s first all-in-one medical cannabis e-clinic has taken a look at the industry’s progress
Read More
Inhalable medicines are already widely used to treat conditions such as asthma, epilepsy, allergies and Parkinson’s but delivery options have been limited due to user accessibility, cost, and impact on the environment, 1nhaler said. The company claims to have developed a way of enabling many different dry powder drugs to be delivered in a low-cost
Read More
OSP: Can you tell us a bit more about the Sally Hollis Memorial Lecture? JV-R: The Sally Hollis Memorial Lecture was established in 2021 in memory of Professor Sally Hollis. Sally was a much-loved and highly respected member of not just the Phastar team but the wider medical statistics community. Sally was best known for
Read More
The life sciences advisory board indicates a continued focus on regulatory complaint and transparent methods for rapid and responsible acceleration of innovation for life science partners on the Evidence Network. The board will consist of executives from the world’s preeminent pharma companies including Moderna, Novartis among others. This latest announcement comes hot on the heels
Read More
PrEP (HIV Pre-exposure Prophylaxis) is a pre-exposure medicine – prophylaxis means to prevent infection and can reduce the risk of contracting HIV when taken as instructed. PrEP contains existing HIV treatment drugs tenofovir disoproxil and emtricitabine and was used in the PrEP Impact Trial that involved 157 sexual health services and more than 24,000 participants
Read More
During the trial, EXN407 met all endpoints and displayed ‘encouraging’ biological activity in diabetic patients with retinal eye disease. Dr Catherine Beech, CEO of Exonate, said: “The results from the EXN407 trial are very encouraging, with the data validating the hypothesis that modulating VEGF splicing can lead to clinical benefits.” Diabetic macular oedema is a
Read More
Clerkenwell Health, a leading provider of mental health research, has today (November 28) called for volunteers for the trials which will be looking at whether psychedelics can provide effective treatments for complex mental health conditions. Ideally, the company would like to recruit a diverse group of volunteers, from right across the country and aged between 18-65,
Read MoreOSP: Can you tell us a bit more about the Sally Hollis Memorial Lecture? JV-R: The Sally Hollis Memorial Lecture was established in 2021 in memory of Professor Sally Hollis. Sally was a much-loved and highly respected member of not just the Phastar team but the wider medical statistics community. Sally was best known for
Read More
As a result, the company claims it is now the only multi-modality vaccine and biologics development and manufacturing organisation in Singapore capable of end-to-end product development. “The opening of the ACES facility marks a significant milestone in our commitment to advancing global public health through innovation and research,” Dr Raman Rao, CEO of Hilleman Laboratories
Read More
The webinar will be broadcasting on Wednesday, December 6 at 10am CST (Chicago) and 5pm CET (Paris) and will last for 60 minutes. There will be an opportunity to submit questions throughout. We have three extremely knowledgeable and forward-looking members on the panel including Dawn Anderson from Deloitte who is managing director of the company’s
Read More
“Across the board, the CDMO industry has noticed the difference in the economy. There is a tightening of finances and companies are postponing clinical trials as they maybe focus on some of their later stage molecules,” Brittany Hayes, highly potent platform director at CordenPharma, tells BioPharma Reporter at CPHI Barcelona 2023. During the pandemic, the
Read More
“Across the board, the CDMO industry has noticed the difference in the economy. There is a tightening of finances and companies are postponing clinical trials as they maybe focus on some of their later stage molecules,” Brittany Hayes, highly potent platform director at CordenPharma, tells BioPharma Reporter at CPHI Barcelona 2023. During the pandemic, the
Read More
CellCentric, a UK-based biotechnology company, announced today (November 22) the publication of the paper and how the work builds on pre-clinical and clinical collaborations, notably with Professor Tim Somervaille of the Cancer Research UK Manchester Institute. The paper, titled, Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies, reports on the therapeutic mechanism of
Read More
The company currently has four sites in Livron, France, Leipzig, Germany, Athens, Greece and Kawagoe, Japan. Most recently, Adragos also acquired Fresenius Kabi’s Norwegian sterile pharmaceutical manufacturing site, alongside its partner Prange Group. Crucial to its growth is an emphasis on customer centricity and optimizing new sites, Henny Zijlstra, chief commercial officer at Adragos, told Outsourcing Pharma
Read More
The company currently has four sites in Livron, France, Leipzig, Germany, Athens, Greece and Kawagoe, Japan. Most recently, Adragos also acquired Fresenius Kabi’s Norwegian sterile pharmaceutical manufacturing site, alongside its partner Prange Group. Crucial to its growth is an emphasis on customer centricity and optimizing new sites, Henny Zijlstra, chief commercial officer at Adragos, told Outsourcing Pharma
Read More
Flywheel, a leading medical imaging artificial intelligence (AI) development platform, today announced the launch of its software-as-a-service (SaaS) data management solution on Microsoft Azure. The Flywheel collaboration with Microsoft and NVIDIA helps researchers and healthcare professionals overcome barriers and accelerate the management, curation, and analysis of medical imaging data to extract and mobilize valuable insights
Read More
Nefecon is designed for the treatment of primary immunoglobulin A nephropathy (IgAN) in adults at risk of disease progression. IgAN is a disease in which IgA protein builds up in and damages the filtering part of the kidney (glomerulus). The damage may cause few or no symptoms but blood in the urine is the most common
Read More